Caesarean scar pregnancy: A 10‐year experience

Abstract

There is no consensus regarding the method of choice for managing CSP. Medical management using intralesional methotrexate appears to be an acceptable treatment in clinically stable women.

Local Methotrexate Injection as the First-line Treatment for Cesarean Scar Pregnancy: Review of the Literature

“…Ninety-six cases from 95 women reported in 17 articles were reviewed [2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18]. Among these articles, 7 were retrospective reviews [2,[4][5][6][7]10,15], 5 case reports [11,13,14,17,18], 3 case series [3,8,16], 1 letter to the editor [12], and 1 short communication [9].…”

“…Among these articles, 7 were retrospective reviews [2,[4][5][6][7]10,15], 5 case reports [11,13,14,17,18], 3 case series [3,8,16], 1 letter to the editor [12], and 1 short communication [9]. Of the 3 articles in which only statistical data were provided [2,4,6], additional case information was obtained from the corresponding authors of 2 articles through e-mail requests [2,4].…”

“…Although cesarean scar pregnancy (CSP) has been considered a rare form of ectopic pregnancy, its incidence has been increasing in recent years because of an increased rate of cesarean delivery and the increasing availability of early pregnancy ultrasound [1,2]. CSP can lead to lifethreatening consequences such as uterine scar rupture and hemorrhage.…”

“…In recent years, our unit has been using local methotrexate as the primary treatment of CSP [2]. Specifically, local methotrexate is given transabdominally or transvaginally under ultrasound guidance by injection of 25 mg (1 mg/kg body weight before 2012) of methotrexate in the gestational sac or mass.…”

Cesarean Scar Pregnancy: Some Management Options

“…However, the risk of recurrent CSP remains. In a ten year study, twenty-two cases of CSP were reviewed [24]. The conclusion was that there could be no consensus in the management of CSP.…”